Open access
Aug 2026
Multimodal artificial intelligence for personalized hepatocellular carcinoma treatment strategy selection
Background Hepatocellular carcinoma (HCC) treatment selection demands nuanced integration of heterogeneous patient data, yet prevailing predictive models rely on restricted data modalities and oversimplified therapeutic frameworks, compromising clinical translation. Objective We developed and validated a multimodal art...
W. Feng, S. Liu, Z. Yang et al.
· medRxiv · 0 citations